Immunological Complications of Radiation Combined Injury
Immunological Complications of Radiation Combined Injury
批准号:
7560141
负责人:
JAMES A. LEDERER
金额:
$25.06万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-07-03 至 2010-06-30
关键词:
AcetylcysteineAddressAdjuvantAffectAgonistAllopurinolAnimal ModelAnti-Inflammatory AgentsAnti-inflammatoryAntibodiesAntioxidantsAreaBacterial InfectionsBlood PlateletsBurn injuryCell physiologyCellsCharacteristicsClinical DataCommunicable DiseasesCompetenceConditionDataDatabasesDevelopmentDoseEffectivenessExposure toFailureGranulocyte Colony-Stimulating FactorGranulocyte-Macrophage Colony-Stimulating FactorHMGB1 geneHematopoiesisHematopoietic Cell Growth FactorsHomeostasisHost DefenseHumanImmuneImmune responseImmune systemImmunityImmunosuppressive AgentsIndividualInfectionInflammationInflammatoryInflammatory ResponseInjuryIntentionInterleukin-3InvadedInvestigationLigandsLiquid substanceLocationLungMeasuresMediatingMediator of activation proteinModelingMolecularMusNuclear AccidentsOpportunistic InfectionsPatientsPeripheralPharmaceutical PreparationsPhasePhenotypePhysiologicalPredispositionPurposeRadiationRadiation InjuriesRecording of previous eventsRecoveryResearchResearch PersonnelResuscitationRiskRodentSepsisSepsis SyndromeStagingStem Cell FactorStressSyndromeT-LymphocyteTLR2 geneTLR3 geneTestingTherapeutic InterventionThrombopoietinTissuesToll-like receptorsToxinTranslational ResearchTraumaTreatment EffectivenessUric AcidVascular Endothelial Growth Factor Receptor-1Workcancer therapycytokineethyl pyruvateexperienceimmune functionin vivoin vivo Modelinjuredinnovationinsightmicrobialmortalitymouse modeloutcome forecastpathogenpre-clinicalpreventradiation effectresearch studyresponseresponse to injurystatisticstherapy designwoundxanthine oxidase inhibitor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Nuclear accidents or attacks inflict both radiation injury and trauma resulting in a combined injury. While, the extent of the combined injury varies depending on the location of the victim, history indicates that individuals that experience combined injury succumb more readily to their injuries and develop more severe post-injury complications than patients with a single form of injury. The mechanisms responsible for the poor prognosis of combined injury victims are not know. The development of an animal model to study the effects of combined injury on the immune system would significantly advance research addressing the immune complications of combined injury. Therefore, the first phase of this phased innovation project will be to develop a mouse model for combined injury by exploring the effects of differing doses of radiation exposure and burn injury on cells and mediators of the immune system. We will collect data on immunophysiological changes in mice that are induced by radiation, by burn injury, and by combined radiation with burn injury. Experiments will also determine the immune competence of combined injured mice by testing their ability to resist bacterial infections and sepsis. The second phase this project will use this mouse model for combined injury to test the efficacy of using hematopoietic growth factor or Toll-like receptor adjuvants to induce immune cell recovery and stronger host defenses against pathogens in injured mice. During this phase, we will also test whether using counter-inflammatory treatments might protect injured mice from the detrimental effects of radiation, burn, or combined injury on the immune system. The results of these studies will provide us and other investigators with a validated mouse model for radiation combined injury and will significantly advance our understanding of how combined injury disrupts immune system function. Moreover, the findings of experiments testing the efficacy of immune-enhancing or counter-inflammatory treatments will provide insight into which therapeutic intervention might be the most beneficial to combined injury victims. Nuclear accidents or attacks inflict radiation injury and trauma causing what is referred to as combined injury. Combined injury victims develop severe immune system failure, which makes them highly susceptible to dying of infections. This project will develop a mouse model for combined injury that will be used to advance our understanding of how combined injury affects the immune system and this new information will then be used to test the effectiveness of immune-enhancing drugs on their ability to restore normal immune system function in combined injury victims.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting Trained Immunity in Trauma-Induced Immune Dysregulation
-
批准号:10714384
-
项目类别:
-
资助金额:$51.05万
-
财政年份:2023
-
负责人:JAMES A. LEDERER
-
依托单位:
Adaptive Immune Regulation of Traumatic Injury
-
批准号:10415072
-
项目类别:
-
资助金额:$41.46万
-
财政年份:2020
-
负责人:JAMES A. LEDERER
-
依托单位:
Adaptive Immune Regulation of Traumatic Injury
-
批准号:10186694
-
项目类别:
-
资助金额:$41.46万
-
财政年份:2020
-
负责人:JAMES A. LEDERER
-
依托单位:
Adaptive Immune Regulation of Traumatic Injury
-
批准号:10624318
-
项目类别:
-
资助金额:$41.46万
-
财政年份:2020
-
负责人:JAMES A. LEDERER
-
依托单位:
Therapy of acute radiation syndrome and its complications by mesenchymal stromal cells conditioned with Toll-like receptor 9 agonists
-
批准号:9899920
-
项目类别:
-
资助金额:$58.23万
-
财政年份:2018
-
负责人:JAMES A. LEDERER
-
依托单位:
Therapy of acute radiation syndrome and its complications by mesenchymal stromal cells conditioned with Toll-like receptor 9 agonists
-
批准号:10374106
-
项目类别:
-
资助金额:$58.23万
-
财政年份:2018
-
负责人:JAMES A. LEDERER
-
依托单位:
Cellular Systems Core
-
批准号:10454989
-
项目类别:
-
资助金额:$26.71万
-
财政年份:2016
-
负责人:JAMES A. LEDERER
-
依托单位:
Cellular Systems Core
-
批准号:10281359
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2016
-
负责人:JAMES A. LEDERER
-
依托单位:
Single Cell and Immunoanalysis Core
-
批准号:10455094
-
项目类别:
-
资助金额:$14.11万
-
财政年份:2016
-
负责人:JAMES A. LEDERER
-
依托单位:
Single Cell and Immunoanalysis Core
-
批准号:10615219
-
项目类别:
-
资助金额:$14.11万
-
财政年份:2016
-
负责人:JAMES A. LEDERER
-
依托单位:
Cellular Systems Core
-
批准号:10684886
-
项目类别:
-
资助金额:$26.71万
-
财政年份:2016
-
负责人:JAMES A. LEDERER
-
依托单位:
Restoring Immune Function Following Radiation Injuries by TLR9 Agonist Treatment
-
批准号:8660290
-
项目类别:
-
资助金额:$65.95万
-
财政年份:2013
-
负责人:JAMES A. LEDERER
-
依托单位:
Restoring Immune Function Following Radiation Injuries by TLR9 Agonist Treatment
-
批准号:8573161
-
项目类别:
-
资助金额:$58.43万
-
财政年份:2013
-
负责人:JAMES A. LEDERER
-
依托单位:
Injury-Specific Activation of the Immune System
-
批准号:8115690
-
项目类别:
-
资助金额:$41.45万
-
财政年份:2011
-
负责人:JAMES A. LEDERER
-
依托单位:
Injury-Specific Activation of the Immune System
-
批准号:8665375
-
项目类别:
-
资助金额:$41.48万
-
财政年份:2011
-
负责人:JAMES A. LEDERER
-
依托单位:
Injury-Specific Activation of the Immune System
-
批准号:8281415
-
项目类别:
-
资助金额:$41.48万
-
财政年份:2011
-
负责人:JAMES A. LEDERER
-
依托单位:
Injury-Specific Activation of the Immune System
-
批准号:8468920
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2011
-
负责人:JAMES A. LEDERER
-
依托单位:
Immunological Complications of Radiation Combined Injury
-
批准号:7898011
-
项目类别:
-
资助金额:$9.97万
-
财政年份:2009
-
负责人:JAMES A. LEDERER
-
依托单位:
Immunological Complications of Radiation Combined Injury
-
批准号:8127884
-
项目类别:
-
资助金额:$59.54万
-
财政年份:2008
-
负责人:JAMES A. LEDERER
-
依托单位:
Immunological Complications of Radiation Combined Injury
-
批准号:7649465
-
项目类别:
-
资助金额:$16.87万
-
财政年份:2008
-
负责人:JAMES A. LEDERER
-
依托单位:
海外基金